EGM
NMRA icon

Engineers Gate Manager’s Neumora Therapeutics NMRA Stock Holding History

Engineers Gate Manager’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,147
Closed -$22.1K – 2395
2025
Q3 		$22.1K Sell
12,147
-9,460
-44% -$15.3K ﹤0.01% 2097
2025
Q2 		$15.8K Sell
21,607
-5,571
-20% -$4.22K ﹤0.01% 2099
2025
Q1 		$27.2K Buy
+27,178
New +$46.5K ﹤0.01% 2072

Other funds holding NMRA

SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return

Engineers Gate Manager's NMRA Position: Q4 2025 in Review

Engineers Gate Manager sold out of Neumora Therapeutics (NMRA) in Q4 2025, closing a stake of 12,147 shares — an estimated $22.1K sold.

Engineers Gate Manager first reported a position in NMRA in Q1 2025 and held it in 3 quarters. The position peaked at $27.2K in Q1 2025. 102 funds tracked by Wall St. Rank hold NMRA as of Q4 2025.

  • Engineers Gate Manager reported no remaining Neumora Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 12,147 Neumora Therapeutics shares in Q4 2025, an estimated $22.1K.
  • Engineers Gate Manager first reported a position in Neumora Therapeutics in Q1 2025 and held it in 3 quarters.
  • Engineers Gate Manager's Neumora Therapeutics position peaked at $27.2K in Q1 2025.
  • 102 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q4 2025.

Based on Engineers Gate Manager's 13F filing for Q4 2025, filed 17 Feb 2026.